Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Open accessThe DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Long-QT syndromes are heritable diseases associated with prolongation of the QT interval on an electrocardiogram and a high risk of sudden cardiac death due to ventricular tachyarrhythmia. In long-QT syndrome type 1, mutations occur in the KCNQ1 gene, which encodes the repolarizing potassium channel mediating the delayed rectifier I(Ks) current. METHODS: We screened a family affected by long-QT syndrome type 1 and identified an autosomal dominant missense mutation (R190Q) in the KCNQ1 gene. We obtained dermal fibroblasts from two family members and two healthy controls and infected them with retroviral vectors encoding the human transcription factors OCT3/4, SOX2, KLF4, and c-MYC to generate pluripotent stem cells. With the use of a specific protocol, these cells were then directed to differentiate into cardiac myocytes. RESULTS: Induced pluripotent stem cells maintained the disease genotype of long-QT syndrome type 1 and generated functional myocytes. Individual cells showed a “ventricular,” “atrial,” or “nodal” phenotype, as evidenced by the expression of cell-type–specific markers and as seen in recordings of the action potentials in single cells. The duration of the action potential was markedly prolonged in “ventricular” and “atrial” cells derived from patients with long-QT syndrome type 1, as compared with cells from control subjects. Further characterization of the role of the R190Q–KCNQ1 mutation in the pathogenesis of long-QT syndrome type 1 revealed a dominant negative trafficking defect associated with a 70 to 80% reduction in I(Ks) current and altered channel activation and deactivation properties. Moreover, we showed that myocytes derived from patients with long-QT syndrome type 1 had an increased susceptibility to catecholamine-induced tachyarrhythmia and that beta-blockade attenuated this phenotype. CONCLUSIONS: We generated patient-specific pluripotent stem cells from members of a family affected by long-QT syndrome type 1 and induced them to differentiate into functional cardiac myocytes. The patient-derived cells recapitulated the electrophysiological features of the disorder. (Funded by the European Research Council and others.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ventricle beat rates showed a positive chronotropic response over the concentration range in both the NRVM and hiPSC-CM ventricles (Fig. 3c), as expected for healthy NRVM59, hiPSC-CM60, engineered hiPSC-CM cardiac tissues16, and human patients61.”
From A tissue-engineered scale model of the heart ventricle (2018) · cites this paper as [60]
In the citing paper
“Various cell models built with iPSC derivatives have been shown to resemble in vivo or primary cell counterparts at transcriptional, cellular, and functional levels whilst leaving little interference to the genetic content [4,5,6,7].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Previous studies using iPSC-derived cardiomyocytes from type-1 LQTS patients revealed that the mutation in KCNQ1 caused potassium ion channel dysfunction resulting in sarcolemmal deficiency [5,6].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Tumorous cell lines, although able to proliferate, are often incorporated with unwanted genetic or chromosomal abnormalities, which might induce interference to the resulting outcomes [4,5].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Models built with iPSC derivatives also demonstrate functional and phenotypic traits comparable to their human in vivo parallel [4,5,6].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W., Croft, G. F., Saphier, G., Leibel, R., Goland, R., et al. (2008) · Science · doi:10.1126/science.1158799 · Cited by 1,962
Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G. W., Cook, E. G., Hargus, G., Blak, A., Cooper, O., Mitalipova, M., et al. (2009) · Cell · doi:10.1016/j.cell.2009.02.013 · Cited by 1,549
Risk Stratification in the Long-QT Syndrome
Priori, S. G., Schwartz, P. J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., Vicentini, A., Spazzolini, C., Nastoli, J., Bottelli, G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022147 · Cited by 1,459
Induced pluripotent stem cells from a spinal muscular atrophy patient
Ebert, A. D., Yu, J., Rose, F. F., Mattis, V. B., Lorson, C. L., Thomson, J. A., & Svendsen, C. N. (2009) · Nature · doi:10.1038/nature07677 · Cited by 1,441
Stem Cells, the Molecular Circuitry of Pluripotency and Nuclear Reprogramming
Jaenisch, R., & Young, R. (2008) · Cell · doi:10.1016/j.cell.2008.01.015 · Cited by 1,427
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,407
Research works printed but not linked: 2
- Freund C, 2010, Neth Heart J, 18, 51
- Brunner M, 2008, J Clin Invest, 118, 2246
Cited by
Items 801–900 of 1,000
Using iPSC Models to Probe Regulation of Cardiac Ion Channel Function
Bruyneel, A. A. N., McKeithan, W. L., Feyen, D. A. M., & Mercola, M. A. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-1000-0 · Cited by 8
Cardiovascular Regeneration via Stem Cells and Direct Reprogramming: A Review
Lee, C.-S., Kim, J., Cho, H., & Kim, H.-S. (2022) · Korean Circulation Journal · doi:10.4070/kcj.2022.0005 · Cited by 8
Regulatory aspects of small molecule drugs for heart regeneration
Rodgers, K. E., Papinska, A., & Mordwinkin, N. M. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.06.013 · Cited by 8
Human iPS cell models of Jervell and Lange-Nielsen syndrome
Bellin, M., & Greber, B. (2015) · Rare Diseases · doi:10.1080/21675511.2015.1012978 · Cited by 8
Self-citationLuecke, L. B., Waas, M., & Gundry, R. L. (2019) · Current Protocols in Stem Cell Biology · doi:10.1002/cpsc.94 · Cited by 8
Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy
Panda, A., Gurusamy, N., Rajasingh, S., Carter, H.-K., Thomas, E. L., & Rajasingh, J. (2020) · Differentiation · doi:10.1016/j.diff.2019.12.001 · Cited by 8
Tokuyama, T., Ahmed, R. E., Chanthra, N., Anzai, T., & Uosaki, H. (2021) · Biology · doi:10.3390/biology10100981 · Cited by 10
Altomare, C., Bartolucci, C., Sala, L., Balbi, C., Burrello, J., Pietrogiovanna, N., Burrello, A., Bolis, S., Panella, S., Arici, M., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04674-9 · Cited by 8
Liebau, S., Kleger, A., Levin, M. G., & Yu, S. P. (2013) · Stem Cells International · doi:10.1155/2013/238635 · Cited by 8
The Promise and Therapeutic Potential of Human ES and iPS Cells
Lu, S., Lee, R. J., Napoli, C., Oh, S. K. W., Kimbrel, E. A., & Feng, Q. (2011) · Stem Cells International · doi:10.4061/2011/959275 · Cited by 8
Pleiotropic mutations in ion channels: What lies behind them?
Crotti, L. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.10.005 · Cited by 8
The Unstoppable Attraction for Induced Pluripotent Stem Cells
Gnecchi, M., & Schwartz, P. J. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.019 · Cited by 9
Lyon, A. R. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.07.716 · Cited by 8
Safety pharmacology 2023 and implementation of the ICH E14/S7B Q&A guidance document
Pugsley, M. K., Koshman, Y. E., Foley, C. M., Winters, B. R., Authier, S., & Curtis, M. J. (2023) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2023.107300 · Cited by 8
May, A., Ventura, T., Fidanza, A., Volmer, H., Taylor, H., Romanò, N., D’Souza, S. L., Bieker, J. J., & Forrester, L. M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1148013 · Cited by 7
Wu, H., Hamilton, C., Porritt, H., Winbo, A., & Zeltner, N. (2024) · The Journal of Physiology · doi:10.1113/jp286416 · Cited by 7
Early Atrial Remodeling Drives Arrhythmia in Fabry Disease
Roy, A., O’Shea, C., Dasí, A., Patel, L., Cumberland, M. J., Nieves, D. J., Canagarajah, H., Thompson, S., Azad, A. J., Price, A. M., et al. (2025) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.124.013352 · Cited by 8
Recognizing heart cells in a crowd
Kamp, T. J. (2011) · Nature Methods · doi:10.1038/nmeth.1780 · Cited by 7
Paci, M., Passini, E., Severi, S., Hyttinen, J., & Rodríguez, B. (2016) · Computing in cardiology · doi:10.22489/cinc.2016.345-232 · Cited by 7
Synková, I., Bébarová, M., Andršová, I., Chmelíková, L., Švecová, O., Hošek, J., Pásek, M., Vít, P., Valášková, I., Gaillyová, R., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81670-1 · Cited by 7
Gene and stem cell therapy for inherited cardiac arrhythmias
Zhang, Z., Barajas-Martínez, H., Jiang, H., Huang, C.-X., Antzelevitch, C. N., Xia, H., & Hu, D. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108596 · Cited by 7
Stem cells in pediatric cardiology
Patel, P., & Mital, S. R. (2013) · European Journal of Pediatrics · doi:10.1007/s00431-012-1920-4 · Cited by 8
Tadros, R., Cadrin‐Tourigny, J., Abadir, S., Rivard, L., Nattel, S., Talajic, M. R., & Khairy, P. (2015) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2015.1049156 · Cited by 8
Jones, A. R. C., Edwards, D. H., Cummins, M. J., Williams, A. J., & George, C. H. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00089 · Cited by 7
Brugada, P., Brugada, R., Campuzano, Ó., Sarquella‐Brugada, G., Brugada, P., Brugada, V., & Brugada, J. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2856-5.00092-3 · Cited by 7
Molecular Insights into Short QT Syndrome
Perike, S., & McCauley, M. D. (2018) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2018.090302 · Cited by 7
Policarová, M., Novotný, T., & Bébarová, M. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.11.012 · Cited by 7
Trieschmann, J., Haustein, M., Köster, A., Hescheler, J., Brockmeier, K., Bennink, G. B. W. E., & Hannes, T. (2019) · Stem Cells International · doi:10.1155/2019/6096294 · Cited by 7
Zhang, F., Meier, A. B., Poch, C. M., Tian, X. Y., Engelhardt, S. H., Sinnecker, D., Lipp, P., Laugwitz, K., Moretti, A., & Dorn, T. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1038867 · Cited by 8
Self-citationWill Engineered T Cells Expressing CD20 scFv Eradicate Melanoma?
Somasundaram, R., Villanueva, J., & Herlyn, M. (2011) · Molecular Therapy · doi:10.1038/mt.2011.46 · Cited by 7
Recapitulating Long-QT Syndrome Using Induced Pluripotent Stem Cell Technology
Dirschinger, R. J., Goedel, A., Moretti, A., Laugwitz, K., & Sinnecker, D. (2012) · Pediatric Cardiology · doi:10.1007/s00246-012-0286-8 · Cited by 7
Self-citationPhenotyping Patient-Derived Cells for Translational Studies in Cardiovascular Disease
Shaw, S. Y., & Brettman, A. D. (2011) · Circulation · doi:10.1161/circulationaha.111.043943 · Cited by 9
Advancements in Induced Pluripotent Stem Cell Technology for Cardiac Regenerative Medicine
Suh, C. Y., Wang, Z., Bártulos, Ó., & Qyang, Y. (2014) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248414523676 · Cited by 8
Generation of Human-Induced Pluripotent Stem Cells by Lentiviral Transduction
Moore, J. C. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-348-0_4 · Cited by 7
Pluripotent Stem Cells and Their Dynamic Niche
Reinwald, Y., Bratt, J. A. J., & Haj, A. J. E. (2016) · InTech eBooks · doi:10.5772/62671 · Cited by 10
Yamakawa, H. (2016) · Inflammation and Regeneration · doi:10.1186/s41232-016-0028-z · Cited by 7
Dahlmann, J., Awad, G., Dolny, C., Weinert, S., Richter, K., Fischer, K., Munsch, T., Leßmann, V., Volleth, M., Zenker, M., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192652 · Cited by 8
Functionalization of soft materials for cardiac repair and regeneration
Kuraitis, D., Hosoyama, K., Blackburn, N. J. R., Deng, C., Zhong, Z., & Suuronen, E. J. (2019) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2019.1572587 · Cited by 8
What Now With Screening Electrocardiography?
Lauer, M. S. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-6-201109200-00011 · Cited by 7
Sinnecker, D., Moretti, A., & Laugwitz, K. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht130 · Cited by 8
Self-citationInduced Pluripotent Stem Cells in Long-QT Syndrome
Masuda, S., & Hanazono, Y. (2011) · New England Journal of Medicine · doi:10.1056/nejmc1012529 · Cited by 7
Macadangdang, J. R., Miklas, J. W., Smith, A. S. T., Choi, E., Leung, W. W., Wang, Y., Guan, X., Lee, S., Salick, M. R., Regnier, M., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/456301 · Cited by 7
Congenital Long QT Syndrome: A Focus on Risk Stratification and Management
Ranganathan, D., Grondin, S., Hadjeres, R., & Joza, J. E. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm36779 · Cited by 8
Bain, J., Barrs, R. W., & Mei, Y. (2026) · npj Biomedical Innovations. · doi:10.1038/s44385-025-00048-4 · Cited by 7
Induced Pluripotent Stem Cells as Human Disease Models
Dimos, J. T., Griswold‐Prenner, I., Grs̆ković, M., Irion, S., Johnson, C., & Vaisberg, E. A. (2011) · Annual reports in medicinal chemistry · doi:10.1016/b978-0-12-386009-5.00005-9 · Cited by 6
Lui, K. O., Stachel, M., Lieu, D. K., Li, R. A., & Bu, L. (2012) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2012.09.001 · Cited by 7
Gowran, A., Rasponi, M., Visone, R., Nigro, P., Perrucci, G. L., Righetti, S., Zanobini, M., & Pompilio, G. (2016) · Stem Cells International · doi:10.1155/2016/4287158 · Cited by 7
Xiang, H., Xu, H., Tan, B., Yi, Q., Zhang, X., Wang, R., Chen, T., Xie, Q., Tian, J., & Zhu, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098112 · Cited by 7
Butler, A. S., Ascione, R., Marrion, N. V., Harmer, S. C., & Hancox, J. C. (2024) · Scientific Reports · doi:10.1038/s41598-024-53571-6 · Cited by 6
Stem cell models of inherited arrhythmias
Ryan, T. L., & Roberts, J. D. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00451-x · Cited by 6
Using induced pluripotent stem cells for drug discovery in arrhythmias
Teles, D., & Fine, B. M. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2360420 · Cited by 6
iPSC-Derived Cardiomyocytes as a Disease Model to Understand the Biology of Congenital Heart Defects
Pushpan, C. K., & Kumar, S. R. (2024) · Cells · doi:10.3390/cells13171430 · Cited by 6
Synthetic embryology of the human heart
Paredes-Espinosa, M. B., & Paluh, J. L. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1478549 · Cited by 8
Heart Muscle Tissue Engineering: Advantages and Challenges in Cardiac Microtissues
Coffee, M., Biswanath, S., Bolesani, E., & Zweigerdt, R. (2020) · Learning materials in biosciences · doi:10.1007/978-3-030-33923-4_6 · Cited by 6
Sigalas, C., Cremer, M. A., Winbo, A., Bose, S. J., Ashton, J. L., Bub, G., Montgomery, J., & Burton, R. A. B. (2020) · Royal Society Open Science · doi:10.1098/rsos.200265 · Cited by 4
Zhao, Y., Eng, G. M., Lee, B. W., Radisic, M., & Vunjak‐Novakovic, G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818422-6.00033-2 · Cited by 7
Induced pluripotent stem cell-based models: Are we ready for that heart in a dish?
Bissoli, I., D’Adamo, S., Pignatti, C., Agnetti, G., Flamigni, F., & Cetrullo, S. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1129263 · Cited by 7
RNA interference-based therapeutics for inherited long QT syndrome
Li, G., Ma, S., & Sun, C. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2573 · Cited by 6
Future challenges for patient-specific induced pluripotent stem cells in cardiovascular medicine
Sun, X., Tan, G., & Liew, R. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.88 · Cited by 6
Programmatic change: lung disease research in the era of induced pluripotency
Ikonomou, L., Hemnes, A. R., Bilousova, G., Hamid, R., Loyd, J. E., Hatzopoulos, A. K., Kotton, D. N., Majka, S. M., & Austin, E. D. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00255.2011 · Cited by 6
Induced Pluripotent Stem Cells in Regenerative Medicine
Pane, L. S., My, I., & Moretti, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-27610-6_3 · Cited by 10
Self-citationGoedel, A., Zawada, D. M., Zhang, F., Chen, Z., Moretti, A., & Sinnecker, D. (2018) · Journal of Visualized Experiments · doi:10.3791/58134 · Cited by 8
Self-citationRawat, N., & Singh, M. K. (2017) · Veterinary World · doi:10.14202/vetworld.2017.640-649 · Cited by 8
Miranda, C. C., Fernandes, T. G., Diogo, M. M., & Cabral, J. M. S. (2019) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2019_117 · Cited by 8
KCNQ1 G219E and TRPM4 T160M polymorphisms are involved in the pathogenesis of long QT syndrome
Zhao, Y., Feng, M., Shang, L., Sun, H., Zhou, X., Lu, Y., Zhang, L., Xing, Q., Li, Y., & Tang, B. (2021) · Medicine · doi:10.1097/md.0000000000024032 · Cited by 6
Translational potential of hiPSCs in predictive modeling of heart development and disease
Mansfield, C., Zhao, M., & Basu, M. (2022) · Birth Defects Research · doi:10.1002/bdr2.1999 · Cited by 6
Moon, S., Bae, D., Jung, T., Chung, E.-B., Jeong, Y.-H., Park, S., & Chung, H. (2017) · International Journal of Stem Cells · doi:10.15283/ijsc17024 · Cited by 7
Cardiac Regeneration in Left Ventricular Dysfunction: Are We Asking the Right Questions?
van der Pol, A., Domian, I. J., & van der Meer, P. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr160 · Cited by 6
Personalized medicine and the role of induced pluripotent stem cells
van der Heyden, M. A. G., & Jonsson, M. K. B. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs242 · Cited by 6
Callaway, E. (2011) · Nature · doi:10.1038/469279a · Cited by 6
Landmark Approach to Generating Human Stem Cells
Daubman, S. (2011) · Circulation Research · doi:10.1161/res.0b013e31820d7dd1 · Cited by 6
Uysal, F., Türkgenç, B., Toksoy, G., Bostan, Ö., Evke, E., Uyguner, Z. O., Yakıcıer, C., Kayserili, H., Çil, E., & Temel, Ş. G. (2017) · BMC Medical Genetics · doi:10.1186/s12881-017-0474-8 · Cited by 5
Defining Cardiomyocyte Repolarization Response to Pharmacotherapy in Long‐QT Syndrome Type 3
Ge, N., Li, R., Liu, M., Xia, W., O'Brien, S. T., McInerney, V., Galvin, J., Ward, D., McGorrian, C., O’Brien, T., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.034690 · Cited by 6
Li, Q., Wang, Y., Wang, B., Lv, T., & Zhang, P. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm28251 · Cited by 6
Kim, Y. H., Son, Y. H., Choi, Y., Kim, M. S., Park, S., & Lee, K. Y. (2026) · Microsystems & Nanoengineering · doi:10.1038/s41378-026-01249-6 · Cited by 8
Campbell, K. A., Terzic, A., & Nelson, T. J. (2015) · Regenerative Medicine · doi:10.2217/rme.15.41 · Cited by 5
Advances in Genetic Reprogramming: Prospects from Developmental Biology to Regenerative Medicine
Dhanjal, D. S., Singh, R., Sharma, V., Nepovimová, E., Adam, V., Kuča, K., & Chopra, C. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230503144619 · Cited by 5
Krogulec, E., Dobosz, A. M., Stefanowski, N., Kendziorek, M., Janikiewicz, J., & Dobrzyń, A. (2025) · Kardiologia Polska · doi:10.33963/v.phj.104577 · Cited by 5
Computational modelling of LQT1 in human induced pluripotent stem cell derived cardiomyocytes
Paci, M., Hyttinen, J., & Severi, S. (2013) · Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) · Cited by 5
A Simulation-Based Method to Study the LQT1 Syndrome Remotely Using the EMI Model
Domínguez-Rivera, S. A., Reimer, J., Green, K. R., Zolfaghari, R., & Spiteri, R. J. (2021) · Advances in Science, Technology & Innovation/Advances in science, technology & innovation · doi:10.1007/978-3-030-14647-4_12 · Cited by 7
Experimental Model of Cardiotoxicity
Erbaş, O., Altuntaş, İ., Çağlar, Ö., Özyılmaz, E., Sari, E., Üzümcü, İ., & Erbakan, K. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101401 · Cited by 6
Recent Status in Brugada Syndrome
Bayrak, F., & Brugada, P. (2022) · Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology · doi:10.5543/tkda.2022.21020 · Cited by 6
Zykaj, E., Abboud, C., Asadi, P., Warsame, S., Almousa, H. A., Milev, M. P., Greco, B. M., López‐Sánchez, M., Bratkovic, D., Kachroo, A. H., et al. (2024) · Cells · doi:10.3390/cells13171457 · Cited by 6
Muerte súbita cardiaca en el corazón estructuralmente normal: una actualización
Melchor, L. G., Villarreal-Molina, M. T., Iturralde-Torres, P., & Medeiros‐Domingo, A. (2014) · Archivos de cardiología de México · doi:10.1016/j.acmx.2014.04.002 · Cited by 10
Induced pluripotent stem cell modeling of complex genetic diseases
Hinson, J. T., Nakamura, K., & Wu, S. M. (2012) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2012.04.002 · Cited by 5
Fujita, J., & Sano, M. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.04.002 · Cited by 5
Zhu, S., Cawley, S. M., Bloch, K. D., & Huang, P. L. (2013) · Cardiovascular System · doi:10.7243/2052-4358-1-10 · Cited by 5
Current Technology in the Diagnosis of Developmentally Related Lung Disorders
Hamvas, A. (2012) · Neonatology · doi:10.1159/000337356 · Cited by 5
An intrinsic, label-free signal for identifying stem cell-derived cardiomyocyte subtype
Chang, C.-W., Kao, H. K. J., Yechikov, S., Lieu, D. K., & Chan, J. W. (2019) · Stem Cells · doi:10.1002/stem.3127 · Cited by 5
Martewicz, S., Magnussen, M., & Elvassore, N. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00384 · Cited by 5
Human pluripotent stem cell–based cardiovascular disease modeling and drug discovery
Liu, G., Liu, Z., & Cao, N. (2021) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-021-02542-1 · Cited by 5
Ji, S.-J., Tu, W., Huang, C., Chen, Z., Ren, X., He, B., Ding, X., Chen, Y., & Xie, X. (2022) · Molecules and Cells · doi:10.14348/molcells.2022.0077 · Cited by 5
Duehmke, R. M., Pearcey, S., Stefaniak, J. D., Guzadhur, L., Jeevaratnam, K., Costopoulos, C., Pedersen, T. H., Grace, A. A., & Huang, C. L.-H. (2012) · Acta Physiologica · doi:10.1111/j.1748-1716.2012.02443.x · Cited by 5
Beating in a dish: new hopes for cardiomyocyte regeneration
Gu, Y., Yi, F., Liu, G., & Belmonte, J. C. I. (2012) · Cell Research · doi:10.1038/cr.2012.163 · Cited by 5
Human pluripotent stem cell-derived cardiovascular progenitors for heart regeneration
Lui, K. O., Stachel, M., Li, R. A., & Bu, L. (2012) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2012.08.003 · Cited by 5
Wang, Y. (2014) · New Journal of Science · doi:10.1155/2014/756240 · Cited by 6
Rody, E., Zwaig, J., Derish, I., Khan, K., Kachurina, N., Gendron, N., Giannetti, N., Schwertani, A. G., & Cecere, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910279 · Cited by 4
Pluripotent Stem Cells to Model Human Cardiac Diseases
Calvin, C., & Charles, C. (2013) · InTech eBooks · doi:10.5772/54373 · Cited by 5
Stem cells therapy for regenerative medicine: Principles of present and future practice
Andrades, J. A., Becerra, J., Muñoz‐Chápuli, R., Martínez, S., Raya, Á., García-Sancho, J., & Moraleda, J. M. (2014) · Journal of Biomedical Science and Engineering · doi:10.4236/jbise.2014.72008 · Cited by 5
Perspective from the heart: The potential of human pluripotent stem cell‐derived cardiomyocytes
Xu, X. Q., & Sun, W. Y. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24359 · Cited by 4
Metadata
- Authors
- Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., Seyfarth, M., Sinnecker, D., Schömig, A., & Laugwitz, K.-L.
- Affiliations
- TUM Klinikum (DE)
- Deutsches Herzzentrum München (DE)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-10-07
- Volume
- 363
- Issue
- 15
- Pages
- 1397-1409
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2104996733
- Cited by
- 1,251
- References
- 40
- Citations by year
- 2026: 26 · 2025: 26 · 2024: 43 · 2023: 49 · 2022: 51 · 2021: 79 · 2020: 56 · 2019: 69 · 2018: 69 · 2017: 89 · 2016: 90 · 2015: 111 · 2014: 90 · 2013: 116 · 2012: 143
- FWCI
- 88.47
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- LQT1, KCNQ1, induced pluripotent stem cells, patient-specific disease models, cardiomyocyte differentiation, action potential prolongation, delayed rectifier potassium current, beta-adrenergic blockade, sudden cardiac death, ventricular repolarization
- MeSH terms
- Kruppel-Like Factor 4, Action Potentials, Adrenergic beta-Antagonists, Adult, Aged, Cardiotonic Agents, Child, Female, Fibroblasts, Humans, Isoproterenol, Male, Pedigree, Phenotype, Potassium Channels, Gene Expression, Mutation, Missense, Reverse Transcriptase Polymerase Chain Reaction, Potassium Channel Blockers, Romano-Ward Syndrome, Myocytes, Cardiac, KCNQ1 Potassium Channel, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.